Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Novartis
Baxter
McKesson
Chinese Patent Office
Daiichi Sankyo
Chubb
Mallinckrodt
Dow
US Department of Justice

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,438,927

« Back to Dashboard

Summary for Patent: 7,438,927
Title:Methods of treatment using a gastric retained gabapentin dosage
Abstract:A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
Inventor(s): Berner; Bret (El Granada, CA), Hou; Sui Yuen Eddie (Foster City, CA), Gusler; Gloria M. (Cupertino, CA)
Assignee: Depomed, Inc. (Menlo Park, CA)
Application Number:10/280,309
Patent Claim Types:
see list of patent claims
Use; Dosage form; Formulation;

Drugs Protected by US Patent 7,438,927

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Depomed Inc GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA ➤ Sign Up
Depomed Inc GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 BX RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,438,927

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,592,481 Gastric retentive gabapentin dosage forms and methods for using same ➤ Sign Up
7,612,112 Methods of treatment using a gastric retained gabapentin dosage ➤ Sign Up
8,192,756 Gastric retained gabapentin dosage form ➤ Sign Up
8,409,613 Gastric retained gabapentin dosage form ➤ Sign Up
8,580,303 Gastric retained gabapentin dosage form ➤ Sign Up
8,231,905 Gastric retained gabapentin dosage form ➤ Sign Up
8,333,991 Gastric retained gabapentin dosage form ➤ Sign Up
8,440,232 Methods of treatment using a gastric retained gabapentin dosage ➤ Sign Up
8,333,992 Gastric retained gabapentin dosage form ➤ Sign Up
8,252,332 Gastric retained gabapentin dosage form ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,438,927

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2002348828 ➤ Sign Up
Australia 2005267738 ➤ Sign Up
Australia 2006332690 ➤ Sign Up
Canada 2464322 ➤ Sign Up
Canada 2575555 ➤ Sign Up
Canada 2635466 ➤ Sign Up
China 101484153 ➤ Sign Up
Denmark 1439825 ➤ Sign Up
European Patent Office 1439825 ➤ Sign Up
European Patent Office 1773311 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Fish and Richardson
Chinese Patent Office
Argus Health
Medtronic
McKinsey
Cerilliant
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot